Pharmacokinetics and Pharmacodynamics Clinical Pharmacokinetics, Platelet Response, and Safety of Eltrombopag at Supratherapeutic Doses of up to 200 mg Once Daily in Healthy Volunteers-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics Clinical Pharmacokinetics, Platelet Response, and Safety of Eltrombopag at Supratherapeutic Doses of up to 200 mg Once Daily in Healthy Volunteers

Published:2011-03 Issue:3 Volume:51 Page:301-308
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Matthys Gemma,Park Jung Wook,McGuire Sandra,Wire Mary Beth,Bowen Carolyn,Williams Daphne,Jenkins Julian,Peng Bin

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270010368677/fullpdf

Reference12 articles.

1. Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist;Jenkins;Blood,2007

2. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies;Kuter;Blood,2002

3. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production;Kaushansky;Oncogene,2002

4. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura;Bussel;N Engl J Med,2007

5. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial;Bussel;Lancet,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia;European Journal of Clinical Pharmacology;2022-08-03

2. Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an M^pro Protease Inhibitor for Treatment of SARS-CoV-2;2022-07-18

3. Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro;Blood Advances;2021-12-30

4. Pharmacokinetic Evaluation of Eltrombopag in ITP Pediatric Patients;Frontiers in Pharmacology;2021-12-06

5. Interference of eltrombopag with bilirubin measurements on the Vitros 5600 analyzer;Journal of Clinical Laboratory Analysis;2021-06-19